NEZAM H. AFDHAL, MD | CONDITIONS | FEBRUARY 7, 2015
The really incredible advances in the treatment of hepatitis C bring to life several relevant questions as we move forward into 2015. First, who should be treating hepatitis C patients (primary care providers, gastroenterologists, infectious disease specialists)? Second, can we really afford to use these new treatments? I recently discussed this topic with my GI and hepatology colleagues in AGA Perspectives, the bi-monthly opinion magazine of the American Gastroenterological Association, but it’s time we extend this conversation outside of our community.Continue reading...
No comments:
Post a Comment